Brief: AVROBIO Announces Completion Of Patient Dosing In First Gene Therapy Clinical Trial For Cystinosis

Tectonic Therapeutic

25/10/2022 12:42

Oct 25 (Reuters) - AVROBIO Inc  AVRO.O :
    * AVROBIO ANNOUNCES COMPLETION OF PATIENT DOSING IN FIRST
GENE
THERAPY CLINICAL TRIAL FOR CYSTINOSIS
    * AVROBIO INC- PRELIMINARY DATA FROM TRIAL SUGGEST THAT THIS
APPROACH IS WELL TOLERATED, WITH NO ADVERSE EVENTS RELATED TO
DRUG PRODUCT REPORTED TO DATE

Source text for Eikon:  ID:nBw80NPNPa 
Further company coverage:  AVRO.O 
 ((Reuters.Briefs@thomsonreuters.com;;))